This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Aug;48(4):479-480.

doi: 10.1111/apt.14857.

Editorial: covert hepatic encephalopathy-silent but serious

Affiliations

PMID: 30588699
DOI: 10.1111/apt.14857

Editorial

Editorial: covert hepatic encephalopathy-silent but serious

J Neuberger. Aliment Pharmacol Ther. 2018 Aug.

. 2018 Aug;48(4):479-480.

doi: 10.1111/apt.14857.

Author

Affiliation

¹ Queen Elizabeth Hospital, Birmingham, UK.

PMID: 30588699
DOI: 10.1111/apt.14857

No abstract available

PubMed Disclaimer

Comment in

Editorial: covert hepatic encephalopathy-silent but serious. Authors' reply.
Labenz C, Wörns MA. Labenz C, et al. Aliment Pharmacol Ther. 2018 Aug;48(4):480-481. doi: 10.1111/apt.14867. Aliment Pharmacol Ther. 2018. PMID: 30588692 No abstract available.

Comment on

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Labenz C, et al. Aliment Pharmacol Ther. 2018 Aug;48(3):313-321. doi: 10.1111/apt.14824. Epub 2018 Jun 4. Aliment Pharmacol Ther. 2018. PMID: 29863286

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information